New cancer drug aims to turn tumors back to normal tissue
Disease control
Recruiting now
This early-stage trial is testing a new drug called SON-DP in people with advanced solid tumors that have not responded to standard treatments. The drug works by trying to reprogram cancer cells in the body, turning them back into normal tissue cells instead of killing them. The …
Phase: PHASE1 • Sponsor: Qurgen Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC